Medizinische Universität Wien (AKH Wien, Medical University Vienna and General Hospital Vienna)

Vienna 01090

0 studies enrolling now · 1 studies all time

What they study most

High-risk Large B-cell Lymphoma (LBCL)

Studies at this site

• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling